xRead Articles - November 2022

130

Otolaryngology–Head and Neck Surgery 154(1)

28. Poorten VV, Hart A, Vauterin T, et al. Prognostic index for patients with parotid carcinoma. Cancer . 2009;115:540-550. 29. Godballe C, Schultz JH, Krogdahl A, Møller-Grøntved A˚ , Johansen J. Parotid carcinoma: impact of clinical factors on prognosis in a his tologically revised series. Laryngoscope . 2003;113:1411-1417. 30. Chen AM, Granchi PJ, Garcia J, Bucci MK, Fu KK, Eisele DW. Local-regional recurrence after surgery without post operative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys . 2007;67:982-987. 31. Herman MP, Werning JW, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM. Elective neck management for high-grade salivary gland carcinoma. Am J Otolaryngol . 2013;34:205-208. 32. Valstar MH, van den Brekel MW, Smeele LE. Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the litera ture. Head Neck . 2010;32:1402-1411. 33. Mohanty S, Bilimoria KY. Comparing national cancer regis tries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol . 2014;109:629-630. 34. Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck . 1999;21:297-309. 35. Lim CM, Gilbert MR, Johnson JT, Kim S. Clinical signifi cance of intraparotid lymph node metastasis in primary parotid cancer. Head Neck . 2014;36:1634-1637.

outcome in resectable parotid cancer. Eur J Surg Oncol . 2008; 34:932-937. 20. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H. Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg . 1993;119:517-520. 21. Vander Poorten V, Bradley PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A. Diagnosis and management of parotid carci noma with a special focus on recent advances in molecular biology. Head Neck . 2012;34:429-440. 22. Seethala RR. An update on grading of salivary gland carcino mas. Head Neck Pathol . 2009;3:69-77. 23. Flynn M, Maguire S, Martinez S, Tesmer T. Primary squamous cell carcinoma of the parotid gland: the importance of correct histological diagnosis. Ann Surg Oncol . 1999;6:768-770. 24. Guntinas-Lichius O, Wendt T, Buentzel J, et al. Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, Germany. J Cancer Res Clin Oncol . 2015;141:1679-1688. 25. Kopec T, Mikaszewski B, Jackowska J, Wasniewska Okupniak E, Szyfter W, Wierzbicka M. Treatment of parotid malignancies: 10 years of experience. J Oral Maxillofac Surg . 2015;73:1397-1402. 26. Bron LP, Traynor SJ, McNeil EB, O’Brien CJ. Primary and metastatic cancer of the parotid: comparison of clinical beha vior in 232 cases. Laryngoscope . 2003;113:1070-1075. 27. Cederblad L, Johansson S, Enblad G, Engstrom M, Blomquist E. Cancer of the parotid gland: long-term follow-up. A single centre experience on recurrence and survival. Acta Oncol . 2009;48:549-555.